Cerylid regroups, lays off staff

By Melissa Trudinger
Thursday, 04 September, 2003

Unlisted Melbourne company Cerylid Biosciences has reorganised, necessitating the layoff of a portion of its staff.

But management at the natural products drug discovery company was quick to reassure Australian Biotechnology News that the strategy is not a sign of trouble for the company, but rather a step taken to realign the needs of the business.

"The reorganisation is due to a realignment of projects, and the company's needs going forward," said Cerylid CEO Dr Jackie Fairley.

"Like many in the sector, we're keeping an eye on cash burn, but we're in a strong cash position, with two years of cash available."

Related News

Quitting smoking increases life expectancy even for seniors

Although the benefits of quitting smoking diminish with age, there are still substantial gains...

Stem cell transplants treat blindness in mini pigs

Scientists have successfully transplanted retinas made from stem cells into blind mini pigs,...

Sugary drinks raise cardiovascular disease risk, but occasional sweets don't

Although higher sugar intake raises your risk of certain cardiovascular diseases, consuming sweet...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd